MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
Buy this
Price Non-Member $30.00

Preview this :
Zoom in

, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817381/9781555817381.ch44-1.gif /docserver/preview/fulltext/10.1128/9781555817381/9781555817381.ch44-2.gif
There is no abstract provided for this chapter. We are in the process of generating a full text preview. Please bookmark and return later.
Citation: Vaneechoutte M, Nemec A, KÄmpfer P, Cools P, Wauters G. .
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of FIGURE 1

Identification of miscellaneous GNF. The organisms covered in this chapter belong to a group of taxonomically diverse, Gram-negative, nonfermentative rods and coccobacilli. They all share the common phenotypic features of failing to acidify the butt of KIA or TSI agar or of oxidative-fermentative media, indicating their inability to metabolize carbohydrates by the fermentative pathway. These characteristics are shared with those of the species of the emended genus (chapter 42) and those of the species of genera that previously were named as (chapter 43). , grows slowly and poorly on SBA. forms small colonies as well, but these are already visible after 24 h of incubation. doi:10.1128/9781555817381.ch44.f1

Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2

Differences in the size of the colonies formed by different species isolated from human clinical specimens. The strains were grown on TSA (Oxoid) at 30°C for 24 h. (a) NIPH 384; (b) NIPH 137; (c) NIPH 1034; (d) ATCC 19606. doi:10.1128/9781555817381.ch44.f2

Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3

Gram stain of , showing characteristic doughnut-shaped morphology. doi:10.1128/9781555817381.ch44.f3

Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 5

Gram stain of , showing Gram-negative, coccoid organisms. doi:10.1128/9781555817381.ch44.f5

Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4

Gram stain of , showing pleomorphic, Gram-negative rods with vacuoles. doi:10.1128/9781555817381.ch44.f4

Permissions and Reprints Request Permissions
Download as Powerpoint


1. Rossau R,, Van Landschoot A,, Gillis M,, De Ley J. 1991. Taxonomy of Moraxellaceae fam. nov., a new bacterial family to accommodate the genera Moraxella, Acinetobacter, and Psychrobacter and related organisms. Int J Syst Evol Microbiol 41:310319.
2. Bernardet JF,, Nakagawa Y,, Holmes B, Subcommittee on the taxonomy of Flavobacterium and Cytophaga-like bacteria of the International Committee on Systematics of Prokaryotes. 2002. Proposed minimal standards for describing new taxa of the family Flavobacteriaceae and emended description of the family. Int J Syst Evol Microbiol 52:10491070.
3. Rice EW,, Reasoner DJ,, Johnson CH,, DeMaria LA. 2000. Monitoring for methylobacteria in water systems. J Clin Microbiol 38:42964297.
4. Seifert H,, Strate A,, Pulverer G. 1995. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 74:340349.
5. Davis KA,, Moran KA,, McAllister CK,, Gray PG. 2005. Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg Infect Dis 11:12181224.
6. Oncul O,, Keskin O,, Acar HV,, Kucukardali Y,, Evrenkaya R,, Atasoyu EM,, Top C,, Nalbant S,, Ozkan S,, Emekdas G,, Cavuslu S,, Us MH,, Pahsa A,, Gokben M. 2002. Hospital-acquired infections following the 1999 Marmara earthquake. J Hosp Infect 51:4751.
7. Dijkshoorn L,, Nemec A,, Seifert H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5:939951.
8. Peleg AY,, Seifert H,, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21:538582.
9. Anstey NM,, Currie BJ,, Hassell M,, Palmer D,, Dwyer B,, Seifert H. 2002. Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol 40:685686.
10. Leung WS,, Chu CM,, Tsang KY,, Lo FH,, Lo KF,, Ho PL. 2006. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest 129:102109.
11. Boo TW,, Walsh F,, Crowley B. 2009. Molecular characterization of carbapenem-resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3. J Med Microbiol 58:209216.
12. Chuang YC,, Sheng WH,, Li SY,, Lin YC,, Wang TJ,, Chen YC,, Chang SC. 2011. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia. Clin Infect Dis 52:352360.
13. Seifert H,, Dijkshoorn L,, Gerner-Smidt P,, Pelzer N,, Tjernberg I,, Vaneechoutte M. 1997. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol 35:28192825.
14. van den Broek PJ,, van der Reijden TJ,, van Strijen E,, Helmig-Schurter AV,, Bernards AT,, Dijkshoorn L. 2009. Endemic and epidemic Acinetobacter species in a university hospital: an 8-year survey. J Clin Microbiol 47:35933599.
15. Dortet L,, Legrand P,, Soussy CJ,, Cattoir V. 2006. Bacterial identification, clinical significance, and antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens. J Clin Microbiol 44:44714478.
16. Hung YT,, Lee YT,, Huang LJ,, Chen TL,, Yu KW,, Fung CP,, Cho WL,, Liu CY. 2009. Clinical characteristics of patients with Acinetobacter junii infection. J Microbiol Immunol Infect 42:4753.
17. Karah N,, Haldorsen B,, Hegstad K,, Simonsen GS,, Sundsfjord A,, Samuelsen Ø, Norwegian Study Group of Acinetobacter. 2011. Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway. J Antimicrob Chemother 66:738744.
18. Turton JF,, Shah J,, Ozongwu C,, Pike R. 2010. Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species. J Clin Microbiol 48:14451449.
19. de Beaufort AJ,, Bernards AT,, Dijkshoorn L,, van Boven CP. 1999. Acinetobacter junii causes life-threatening sepsis in preterm infants. Acta Paediatr 88:772775.
20. Pellegrino FL,, Vieira VV,, Baio PV,, dos Santos RM,, dos Santos AL,, Santos NG,, Meohas MM,, Santos RT,, de Souza TC,, da Silva Dias RC,, Santoro-Lopes G,, Riley LW,, Moreira BM. 2011. Acinetobacter soli as a cause of bloodstream infection in a neonatal intensive care unit. J Clin Microbiol 49:22832285.
21. Nemec A,, Dijkshoorn L,, Cleenwerck I,, De Baere T,, Janssens D,, van der Reijden TJ,, Jezek P,, Vaneechoutte M. 2003. Acinetobacter parvus sp. nov., a small-colony-forming species isolated from human clinical specimens. Int J Syst Evol Microbiol 53:15631567.
22. Wisplinghoff H,, Edmond MB,, Pfaller MA,, Jones RN,, Wenzel RP,, Seifert H. 2000. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis 31:690697.
23. Bouvet PJ,, Grimont PA. 1986. Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov. and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii. Int J Syst Evol Microbiol 36:228240.
24. Tjernberg I,, Ursing J. 1989. Clinical strains of Acinetobacter classified by DNA-DNA hybridization. APMIS 97:595605.
25. Karalus R,, Campagnari A. 2000. Moraxella catarrhalis: a review of an important human mucosal pathogen. Microbes Infect 2:547559.
26. Shah SS,, Ruth A,, Coffin SE. 2000. Infection due to Moraxella osloensis: case report and review of the literature. Clin Infect Dis 30:179181.
27. Vaneechoutte M,, Claeys G,, Steyaert S,, De Baere T,, Peleman R,, Verschraegen G. 2000. Isolation of Moraxella canis from an ulcerated metastatic lymph node. J Clin Microbiol 38:38703871.
28. Vaneechoutte M,, Verschraegen G,, Claeys G,, Weise B,, Van den Abeele AM. 1990. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J Clin Microbiol 28:26742680.
29. Davis JM,, Whipp MJ,, Ashhurst-Smith C,, DeBoer JC,, Peel MM. 2004. Mucoid nitrate-negative Moraxella nonliquefaciens from three patients with chronic lung disease. J Clin Microbiol 42:38883890.
30. Rafiq I,, Parthasarathy H,, Tremlett C,, Freeman LJ,, Mullin M. 2011. Infective endocarditis caused by Moraxella nonliquefaciens in a percutaneous aortic valve replacement. Cardiovasc Revasc Med 12:184186.
31. Dien Bard J,, Lewinski M,, Summanen PH,, Deville JG. 2011. Sepsis with prolonged hypotension due to Moraxella osloensis in a non-immunocompromised child. J Med Microbiol 60:138141.
32. Roh KH,, Kim CK,, Koh E,, Kim MS,, Yong D,, Park SC,, Lee K,, Chong Y. 2010. Three cases of Moraxella osloensis meningitis: a difficult experience in species identification and determination of clinical significance. J Korean Med Sci 25:501504.
33. Jannes G,, Vaneechoutte M,, Lannoo M,, Gillis M,, Vancanneyt M,, Vandamme P,, Verschraegen G,, van Heuverswyn H,, Rossau R. 1993. Polyphasic taxonomy leading to the proposal of Moraxella canis sp. nov. for Moraxella catarrhalis-like strains. Int J Syst Bacteriol 43:438449.
34. Dasari S,, Shetty R,, Devasia T. 2011. A rare case of Moraxella lacunata producing combined native mitral and aortic valve endocarditis. Australas Med J 4:386388.
35. Kutlesa M,, Lepur D,, Klinar I,, Rudez I,, Vincelj J,, Bukovski S,, Barsic´ B. 2007. Moraxella lacunata: a rare cause of infective endocarditis. Scand J Infect Dis 39:917919.
36. Bergogne-Bérézin E,, Joly-Guillou ML,, Towner KJ (ed). 1996. Appendix II: selective isolation of Acinetobacter spp. by enrichment cultivation, p 241–242. In Acinetobacter: Microbiology, Epidemiology, Infections, Management. CRC Press, Boca Raton, FL.
37. Vaneechoutte M,, Verschraegen G,, Claeys G,, Van den Abeele AM. 1988. A selective medium for Branhamella catarrhalis, with acetazolamide as a specific inhibitor of Neisseria spp. J Clin Microbiol 26:25442548.
38. O’Hara CM,, Miller JM. 2003. Evaluation of the Vitek 2 ID-GNB assay for identification of members of the family Enterobacteriaceae and other nonenteric gram-negative bacilli and comparison with the Vitek GNI+ card. J Clin Microbiol 41:20962101.
39. Bosshard PP,, Zbinden R,, Abels S,, Böddinghaus B,, Altwegg M,, Böttger EC. 2006. 16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting gram-negative bacteria in the clinical laboratory. J Clin Microbiol 44:13591366.
40. Weyant RS,, Moss CW,, Weaver RE,, Hollis DG,, Jordan JG,, Cook EC,, Daneshvar MI. 1996. Identification of Unusual Pathogenic Gram-Negative Aerobic and Facultatively Anaerobic Bacteria, 2nd ed. Williams and Wilkins, Baltimore, MD.
41. Seng P,, Drancourt M,, Gouriet F,, La Scola B,, Fournier PE,, Rolain JM,, Raoult D. 2009. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 49:543551.
42. Espinal P,, Seifert H,, Dijkshoorn L,, Vila J,, Roca I. 2012. Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS. Clin Microbiol Infect 18:10971103.
43. Vanlaere E,, Sergeant K,, Dawyndt P,, Kallow W,, Erhard M,, Sutton H,, Dare D,, Devreese B,, Samyn B,, Vandamme P. 2008. Matrix-assisted laser desorption ionisation-time-of-flight mass spectrometry of intact cells allows rapid identification of Burkholderia cepacia complex. J Microbiol Methods 75:279286.
44. Mellmann A,, Cloud J,, Maier T,, Keckevoet U,, Ramminger I,, Iwen P,, Dunn J,, Hall G,, Wilson D,, Lasala P,, Kostrzewa M,, Harmsen D. 2008. Evaluation of matrix-assisted laser desorption ionization–time-of-flight mass spectrometry in comparison to 16S rRNA gene sequencing for species identification of nonfermenting bacteria. J Clin Microbiol 46:19461954.
45. Marko DC,, Saffert RT,, Cunningham SA,, Hyman J,, Walsh J,, Arbefeville S,, Howard W,, Pruessner J,, Safwat N,, Cockerill FR,, Bossler AD,, Patel R,, Richter SS. 2012. Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization–time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients. J Clin Microbiol 50:20342039.
46. Mellmann A,, Bimet F,, Bizet C,, Borovskaya AD,, Drake RR,, Eigner U,, Fahr AM,, He Y,, Ilina EN,, Kostrzewa M,, Maier T,, Mancinelli L,, Moussaoui W,, Prévost G,, Putignani L,, Seachord CL,, Tang YW,, Harmsen D. 2009. High interlaboratory reproducibility of matrix-assisted laser desorption ionization–time of flight mass spectrometry-based species identification of nonfermenting bacteria. J Clin Microbiol 47:37323734.
47. Sedo O,, Vorácˇ A,, Zdráhal Z. 2005. Optimization of mass spectral features in MALDI-TOF MS profiling of Acinetobacter species. Syst Appl Microbiol 34:3034.
48. Kempf M,, Bakour S,, Flaudrops C,, Berrazeg M,, Brunel JM,, Drissi M,, Mesli E,, Touati A,, Rolain JM. 2012. Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometry. PLoS One 7:e31676. 10.1371/journal.pone.0031676.
49. Schaller A,, Troller R,, Molina D,, Gallati S,, Aebi C,, Stutzmann Meier P. 2006. Rapid typing of Moraxella catarrhalis subpopulations based on outer membrane proteins using mass spectrometry. Proteomics 6:172180.
50. Mencacci A,, Monari C,, Leli C,, Merlini L,, De Carolis E,, Vella A,, Cacioni M,, Buzi S,, Nardelli E,, Bistoni F,, Sanguinetti M,, Vecchiarelli A. 2013. Typing of nosocomial outbreaks of Acinetobacter baumannii by use of matrix-assisted laser desorption ionization–time of flight mass spectrometry. J Clin Microbiol 51:603606.
51. Petti CA,, Polage CR,, Schreckenberger P. 2005. Is misidentification of microorganisms by conventional methods a laboratory error? Preventing laboratory errors with 16S rRNA gene sequencing. J Clin Microbiol 43:61236125.
52. Su SC,, Vaneechoutte M,, Dijkshoorn L,, Wei YF,, Chen YL,, Chang TC. 2009. Identification of nonfermenting Gram-negative bacteria of clinical importance by an oligonucleotide array. J Med Microbiol 58:596605.
53. Dijkshoorn L,, van Harsselaar B,, Tjernberg I,, Bouvet PJ,, Vaneechoutte M. 1998. Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species. Syst Appl Microbiol 21:3339.
54. Vaneechoutte M,, Rossau R,, De Vos P,, Gillis M,, Janssens D,, Paepe N,, De Rouck A,, Fiers T,, Claeys G,, Kersters K. 1992. Rapid identification of bacteria of the Comamonadaceae with amplified ribosomal DNA-restriction analysis (ARDRA). FEMS Microbiol Lett 93:227234.
55. Catry B,, Boyen F,, Baele M,, Dewulf J,, de Kruif A,, Vaneechoutte M,, Haesebrouck F,, Decostere A. 2007. Recovery of Moraxella ovis from the bovine respiratory tract and differentiation of Moraxella species by tDNA-intergenic spacer PCR. Vet Microbiol 120:375380.
56. Ehrenstein B,, Bernards AT,, Dijkshoorn L,, Gerner-Smidt P,, Towner KJ,, Bouvet PJ,, Daschner FD,, Grundmann H. 1996. Acinetobacter species identification by using tRNA spacer fingerprinting. J Clin Microbiol 34:24142420.
57. Dijkshoorn L,, Nemec A,. 2008. The diversity of the genus Acinetobacter, p 1–34. In Gerischer U (ed), Acinetobacter Molecular Biology. Caister Academic Press, Norwich, United Kingdom.
58. Juni E,. 2005. Genus II. Acinetobacter Brisou and Prévot 1954, p 425–437. In Garrity GM,, Brenner DJ,, Krieg NR,, Staley JT (ed), Bergey’s Manual of Systematic Bacteriology, 2nd ed, vol 2, part B. Springer-Verlag, New York, NY.
59. Alvarez-Perez S,, Lievens B,, Jacquemyn H,, Herrera CM. 2013. Acinetobacter nectaris sp. nov. and Acinetobacter boissieri sp. nov., isolated from floral nectar of wild Mediterranean insect-pollinated plants. Int J Syst Evol Microbiol 63:15321539.
60. Chu YW,, Leung CM,, Houang ET,, Ng KC,, Leung CB,, Leung HY,, Cheng AF. 1999. Skin carriage of acinetobacters in Hong Kong. J Clin Microbiol 37:29622967.
61. Zordan S,, Prenger-Berninghoff E,, Weiss R,, van der Reijden TJ,, van den Broek P,, Baljer G,, Dijkshoorn L. 2011. Multidrug-resistant Acinetobacter baumannii in veterinary clinics, Germany. Emerg Infect Dis 17:17511754.
62. Vaneechoutte M,, Devriese LA,, Dijkshoorn L,, Lamote B,, Deprez P,, Verschraegen G,, Haesebrouck F. 2000. Acinetobacter baumannii-infected vascular catheters collected from horses in an equine clinic. J Clin Microbiol 38:42804281.
63. van den Broek PJ,, Arends J,, Bernards AT,, De Brauwer E,, Mascini EM,, van der Reijden TJ,, Spanjaard L,, Thewessen EA,, van der Zee A,, van Zeijl JH,, Dijkshoorn L. 2006. Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999–2001. Clin Microbiol Infect 12:837843.
64. Marchaim D,, Navon-Venezia S,, Schwartz D,, Tarabeia J,, Fefer I,, Schwaber MJ,, Carmeli Y. 2007. Surveillance cultures and duration of carriage of multi-drug-resistant Acinetobacter baumannii. J Clin Microbiol 45:15511555.
65. Nemec A,, Krizova L,, Maixnerova M,, van der Reijden TJ,, Deschaght P,, Passet V,, Vaneechoutte M,, Brisse S,, Dijkshoorn L. 2011. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol 162:393404.
66. Nemec A,, Musílek M,, Šedo O,, De Baere T,, Maixnerová M,, van der Reijden TJ,, Zdráhal Z,, Vaneechoutte M,, Dijkshoorn L. 2010. Acinetobacter bereziniae sp. nov. and Acinetobacter guillouiae sp. nov., to accommodate Acinetobacter genomic species 10 and 11, respectively. Int J Syst Evol Microbiol 60:896903.
67. Nemec A,, Musílek M,, Maixnerová M,, De Baere T,, van der Reijden TJ,, Vaneechoutte M,, Dijkshoorn L. 2009. Acinetobacter beijerinckii sp. nov. and Acinetobacter gyllenbergii sp. nov., haemolytic organisms isolated from humans. Int J Syst Evol Microbiol 59:118124.
68. Kim D,, Baik KS,, Kim MS,, Park SC,, Kim SS,, Rhee MS,, Kwak YS,, Seong CN. 2008. Acinetobacter soli sp. nov., isolated from forest soil. J Microbiol 46:396401.
69. Vaneechoutte M,, De Baere T,, Nemec A,, van der Reijden TJ,, Dijkshoorn L. 2008. Reclassification of Acinetobacter grimontii Carr et al. 2003 as a later synonym of Acinetobacter junii Bouvet and Grimont 1986. Int J Syst Evol Microbiol 58:937940.
70. Nemec A,, Musílek M,, Vaneechoutte M,, Falsen E,, Dijkshoorn L. 2008. Lack of evidence for “Acinetobacter septicus” as a species different from Acinetobacter ursingii? J Clin Microbiol 46:28262827.
71. Henrichsen J,, Blom J. 1975. Correlation between twitching motility and possession of polar fimbriae in Acinetobacter calcoaceticus. Acta Pathol Microbiol Scand B 83:103115.
72. Mussi MA,, Gaddy JA,, Cabruja M,, Arivett BA,, Viale AM,, Rasia R,, Actis LA. 2010. The opportunistic human pathogen Acinetobacter baumannii senses and responds to light. J Bacteriol 192:63366345.
73. Golic A,, Vaneechoutte M,, Nemec A,, Viale A,, Actis L,, Mussi MA. 2013. Staring at the cold sun: blue light is distributed within the genus Acinetobacter. PLoS One 8:e55059. 10.1371/journal.pone.0055059.
74. Vaneechoutte M,, De Baere T,. 2008. Taxonomy of the genus Acinetobacter, based on 16S ribosomal RNA gene sequences, p 35–60. In Gerischer U (ed), Acinetobacter Molecular Biology. Caister Academic Press, Norwich, United Kingdom.
75. Chang HC,, Wei YF,, Dijkshoorn L,, Vaneechoutte M,, Tang CT,, Chang TC. 2005. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol 43:16321639.
76. Turton JF,, Woodford N,, Glover J,, Yarde S,, Kaufmann ME,, Pitt TL. 2006. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 44:29742976.
77. Grundmann HJ,, Towner KJ,, Dijkshoorn L,, Gerner-Smidt P,, Maher M,, Seifert H,, Vaneechoutte M. 1997. Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J Clin Microbiol 35:30713077.
78. Seifert H,, Dolzani L,, Bressan R,, van der Reijden T,, van Strijen B,, Stefanik D,, Heersma H,, Dijkshoorn L. 2005. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 43:43284335.
79. Minandri F,, D’Arezzo S,, Antunes LC,, Pourcel C,, Principe L,, Petrosillo N,, Visca P. 2012. Evidence of diversity among epidemiologically related carbapenemase-producing Acinetobacter baumannii strains belonging to international clonal lineage II. J Clin Microbiol 50:590597.
80. Turton JF,, Matos J,, Kaufmann ME,, Pitt TL. 2009. Variable number tandem repeat loci providing discrimination within widespread genotypes of Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 28:499507.
81. Zander E,, Nemec A,, Seifert H,, Higgins PG. 2012. Association between β-lactamase-encoding blaOXA-51 variants and DiversiLab rep-PCR-based typing of Acinetobacter baumannii isolates. J Clin Microbiol 50:19001904.
82. Bartual SG,, Seifert H,, Hippler C,, Luzon MA,, Wisplinghoff H,, Rodriguez-Valera F. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 43:43824390.
83. Diancourt L,, Passet V,, Nemec A,, Dijkshoorn L,, Brisse S. 2010. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5:e10034. 10 .1371/journal.pone.0010034.
84. Karah N,, Sundsfjord A,, Towner K,, Samuelsen Ø. 2012. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updat 15:237247.
85. Nemec A,, Dijkshoorn L,, van der Reijden T. 2004. Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic. J Med Microbiol 53:147153.
86. Krizova L,, Nemec A. 2010. A 63 kb genomic resistance island found in a multidrug-resistant Acinetobacter baumannii isolate of European clone I from 1977. J Antimicrob Chemother 65:19151918.
87. Krizova L,, Dijkshoorn L,, Nemec A. 2011. Diversity and evolution of AbaR genomic resistance islands in Acinetobacter baumannii strains of European clone I. Antimicrob Agents Chemother 55:32013206.
88. Higgins PG,, Dammhayn C,, Hackel M,, Seifert H. 2010. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 65:233238.
89. Nemec A,, Krizova L,, Maixnerova M,, Diancourt L,, van der Reijden TJ,, Brisse S,, van den Broek P,, Dijkshoorn L. 2008. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J Antimicrob Chemother 62:484489.
90. Stietz MS,, Ramírez MS,, Vilacoba E,, Merkier AK,, Limansky AS,, Centrón D,, Catalano M. 2013. Acinetobacter baumannii extensively drug resistant lineages in Buenos Aires hospitals differ from the international clones I–III. Infect Genet Evol 14:294301.
91. Turton JF,, Gabriel SN,, Valderrey C,, Kaufmann ME,, Pitt TL. 2007. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect 13:807815.
92. Endo S,, Sasano M,, Yano H,, Inomata S,, Ishibashi N,, Aoyagi T,, Hatta M,, Gu Y,, Yamada M,, Tokuda K,, Kitagawa M,, Kunishima H,, Hirakata Y,, Kaku M. 2012. IMP-1-producing carbapenem-resistant Acinetobacter ursingii from Japan. J Antimicrob Chemother 67:25332534.
93. Park YK,, Jung SI,, Park KH,, Kim SH,, Ko KS. 2012. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea. Int J Antimicrob Agents 39:8185.
94. Roca I,, Espinal P,, Vila-Farrés X,, Vila J. 2012. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace. Front Microbiol 3:148. 10.3389/fmicb.2012.00148.
95. Fournier PE,, Vallenet D,, Barbe V,, Audic S,, Ogata H,, Poirel L,, Richet H,, Robert C,, Mangenot S,, Abergel C,, Nordmann P,, Weissenbach J,, Raoult D,, Claverie JM. 2006. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2:e7. 10.1371/journal.pgen.0020007.
96. Seputiene V,, Povilonis J,, Suziedeliene E. 2012. Novel variants of AbaR resistance islands with a common backbone in Acinetobacter baumannii isolates of European clone II. Antimicrob Agents Chemother 56:19691973.
97. Swenson JM,, Killgore GE,, Tenover FC. 2004. Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods. J Clin Microbiol 42:51025108.
98. Magiorakos AP,, Srinivasan A,, Carey RB,, Carmeli Y,, Falagas ME,, Giske CG,, Harbarth S,, Hindler JF,, Kahlmeter G,, Olsson-Liljequist B,, Paterson DL,, Rice LB,, Stelling J,, Struelens MJ,, Vatopoulos A,, Weber JT,, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268281.
99. Arroyo LA,, García-Curiel A,, Pachón-Ibañez ME,, Llanos AC,, Ruiz M,, Pachón J,, Aznar J. 2005. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J Clin Microbiol 43:903905.
100. Greenberg DE,, Porcella SF,, Stock F,, Wong A,, Conville PS,, Murray PR,, Holland SM,, Zelazny AM. 2006. Granulibacter bethesdensis gen. nov., sp. nov., a distinctive pathogenic acetic acid bacterium in the family Acetobacteraceae. Int J Syst Evol Microbiol 56:26092616.
101. López FC,, de Luna FF,, Delgado MC,, de la RosaII,, Valdezate S,, Nieto JA,, Casal M. 2008. Granulibacter bethesdensis isolated in a child patient with chronic granulomatous disease. J Infect 57:275277.
102. Helsel LO,, Hollis D,, Steigerwalt AG,, Morey RE,, Jordan J,, Aye T,, Radosevic J,, Jannat-Khah D,, Thiry D,, Lonsway DR,, Patel JB,, Daneshvar MI,, Levett PN. 2007. Identification of “Haematobacter,” a new genus of aerobic gram-negative rods isolated from clinical specimens, and reclassification of Rhodobacter massiliensis as “Haematobacter massiliensis comb. nov.” J Clin Microbiol 45:12381243.
103. Vandamme P,, Gillis M,, Vancanneyt M,, Hoste B,, Kersters K,, Falsen E. 1993. Moraxella lincolnii sp. nov., isolated from the human respiratory tract, and reevaluation of the taxonomic position of Moraxella osloensis. Int J Syst Bacteriol 43:474481.
104. Bøvre K,, Fuglesang JE,, Hagen N,, Jantzen E,, Frøholm LO. 1976. Moraxella atlantae sp. nov. and its distinction from Moraxella phenylpyrouvica. Int J Syst Evol Microbiol 26:511521.
105. Speeleveld E,, Fossépré JM,, Gordts B,, Landuyt HW. 1994. Comparison of three rapid methods, tributyrine, 4-methylumbelliferyl butyrate, and indoxyl acetate, for rapid identification of Moraxella catarrhalis. J Clin Microbiol 32:13621363.
106. Bombicino KA,, Almuzara MN,, Famiglietti AM,, Vay C. 2007. Evaluation of pyrrolidonyl arylamidase for the identification of nonfermenting gram-negative rods. Diagn Microbiol Infect Dis 57:101103. (Erratum, 57:473.)
107. Fass RJ,, Barnishan J. 1980. In vitro susceptibility of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. Rev Infect Dis 2:841853.
108. Spangler SK,, Visalli MA,, Jacobs MR,, Appelbaum PC. 1996. Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem. Antimicrob Agents Chemother 40:772775.
109. Rossau R,, Kersters K,, Falsen E,, Jantzen E,, Segers P,, Union A,, Nehls L,, De Ley J. 1987. Oligella, a new genus including Oligella urethralis comb. nov. (formerly Moraxella urethralis) and Oligella ureolytica sp. nov. (formerly CDC group IVe): relationship to Taylorella equigenitalis and related taxa. Int J Syst Evol Microbiol 37:198210.
110. Baqi M,, Mazzulli T. 1996. Oligella infections: case report and review of the literature. Can J Infect Dis 7:377379.
111. Pickett MJ,, von Graevenitz A,, Pfyffer GE,, Pünter V,, Altwegg M. 1996. Phenotypic features distinguishing Oligella urethralis from Moraxella osloensis. Med Microbiol Lett 5:265270.
112. Daneshvar MI,, Hollis DG,, Weyant RS,, Steigerwalt AG,, Whitney AM,, Douglas MP,, Macgregor JP,, Jordan JG,, Mayer LW,, Rassouli SM,, Barchet W,, Munro C,, Shuttleworth L,, Bernard K. 2003. Paracoccus yeeii sp. nov. (formerly CDC group EO-2), a novel bacterial species associated with human infection. J Clin Microbiol 41: 12891294.
113. Juni E,, Heym GA. 1986. Psychrobacter immobilis gen. nov., sp. nov.: genospecies composed of gram-negative, aerobic, oxidase-positive coccobacilli. Int J Syst Evol Microbiol 36:388391.
114. Deschaght P,, Janssens M,, Vaneechoutte M,, Wauters G. 2012. Psychrobacter isolates of human origin, other than Psychrobacter phenylpyruvicus, are predominantly Psychrobacter pulmonis, with emended description of P. faecalis. Int J Syst Evol Microbiol 62:671674.
115. Kämpfer P,, Albrecht A,, Buczolitz S,, Busse HJ. 2002. Psychrobacter faecalis sp. nov., a new species from a bioaerosol originating from pigeon faeces. Syst Appl Microbiol 25:3136.
116. Vela AI,, Collins MD,, Latre MV,, Mateos A,, Moreno MA,, Hutson R,, Dominguez L,, Fernandez-Garayzabal JF. 2003. Psychrobacter pulmonis sp. nov., isolated from the lungs of lambs. Int J Syst Evol Microbiol 53:415419.
117. Wirth SE,, Ayala-del-Río HL,, Cole JA,, Kohlerschmidt DJ,, Musser KA,, Sepúlveda-Torres LD,, Thompson LM,, Wolfgang WJ. 2012. Psychrobacter sanguinis sp. nov., recovered from four clinical specimens over 4-year period. Int J Syst Evol Microbiol 62:4954.
118. Almuzara MN,, Palombarani S,, Tuduri A,, Figuerosa S,, Gianecini A,, Sabater L,, Ramirez MS,, Vay CA. 2011. First case of fulminant sepsis due to Wohlfahrtiimonas chitiniclastica. J Clin Microbiol 49:23332335.
119. Tóth EM,, Schumann P,, Borsodi AK,, Kéki Z,, Kovács AL,, Márialigeti K. 2008. Wohlfahrtiimonas chitiniclastica gen. nov., sp. nov., a new gammaproteobacterium isolated from Wohlfahrtia magnifica (Diptera: Sarcophagidae). Int J Syst Evol Microbiol 58:976981.
120. Rebaudet S,, Genot S,, Renvoise A,, Fournier PE,, Stein A. 2009. Wohlfahrtiimonas chitiniclastica bacteremia in homeless woman. Emerg Infect Dis 15:985987.
121. Moss CW,, Daneshvar MI,, Hollis DG. 1993. Biochemical characteristics and fatty acid composition of Gilardi rod group 1 bacteria. J Clin Microbiol 31:689691.
122. Vogel BF,, Venkateswaran K,, Christensen H,, Falsen E,, Christiansen G,, Gram L. 2000. Polyphasic taxonomic approach in the description of Alishewanella fetalis gen. nov., sp. nov., isolated from a human foetus. Int J Syst Evol Microbiol 50:11331142.
123. Coenye T,, Goris J,, Spilker T,, Vandamme P,, LiPuma JJ. 2002. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov. J Clin Microbiol 40:20622069.
124. Wellinghausen N,, Essig A,, Sommerburg O. 2005. Inquilinus limosus in patients with cystic fibrosis, Germany. Emerg Infect Dis 11:457459.
125. Chiron R,, Marchandin H,, Counil F,, Jumas-Bilak E,, Freydiere AM,, Bellon G,, Husson MO,, Turck D,, Bremont F,, Chabanon G,, Segonds C. 2005. Clinical and microbiological features of Inquilinus sp. isolates from five patients with cystic fibrosis. J Clin Microbiol 43:39383943.
126. Jacquier H,, Carbonnelle E,, Corvec S,, Illiaquer M,, Le Monnier A,, Bille E,, Zahar JR,, Beretti JL,, Jauréguy F,, Fihman V,, Tankovic J,, Cattoir V. 2011. Revisited distribution of nonfermenting Gram-negative bacilli clinical isolates. Eur J Clin Microbiol Infect Dis 30:15791586.
127. Hayes DJr,, , Murphy BS,, Kuhn RJ,, Anstead MI,, Feola DJ. 2009. Mucoid Inquilinus limosus in a young adult with cystic fibrosis. Pediatr Pulmonol 44:619621.
128. Salvador-García C,, Yagüe-Guirao G,, Pastor-Vivero MD,, Sáez-Nieto JA. 2013. Chronic colonization of Inquilinus limosus in a patient with cystic fibrosis: first report in Spain. Enferm Infecc Microbiol Clin 31:414415.
129. Vancanneyt M,, Segers P,, Torck U,, Hoste B,, Bernardet JF,, Vandamme P,, Kersters K. 1996. Reclassification of Flavobacterium odoratum (Stutzer 1929) strains to a new genus, Myroides, as Myroides odoratus comb. nov. and Myroides odoratimimus sp. nov. Int J Syst Bacteriol 46:926932.
130. Benedetti P,, Rassu M,, Pavan G,, Sefton A,, Pellizzer G. 2011. Septic shock, pneumonia, and soft tissue infection due to Myroides odoratimimus: report of a case and review of Myroides infections. Infection 39:161165.
131. Holmes B,, Snell JJ,, Lapage SP. 1979. Flavobacterium odoratum: a species resistant to a wide range of antimicrobial agents. J Clin Pathol 32:7377.
132. Holmes B,, Popoff M,, Kiredjian M,, Kersters K. 1988. Ochrobactrum anthropi gen. nov., sp. nov. from human clinical specimens and previously known as group Vd. Int J Syst Bacteriol 38:406416.
133. Velasco J,, Romero C,, López-Goñi I,, Leiva J,, Díaz R,, Moriyón I. 1998. Evaluation of the relatedness of Brucella spp. and Ochrobactrum anthropi and description of Ochrobactrum intermedium sp. nov., a new species with a closer relationship to Brucella spp. Int J Syst Bacteriol 48:759768.
134. Kämpfer P,, Scholz HC,, Huber B,, Falsen E,, Busse HJ. 2007. Ochrobactrum haematophilum sp. nov. and Ochrobactrum pseudogrignonense sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol 57:25132518.
135. Teyssier C,, Marchandin H,, Jean-Pierre H,, Masnou A,, Dusart G,, Jumas-Bilak E. 2007. Ochrobactrum pseudintermedium sp. nov., a novel member of the family Brucellaceae, isolated from human clinical samples. Int J Syst Evol Microbiol 57:10071013.
136. Saavedra J,, Garrido C,, Folgueira D,, Torres MJ,, Ramos JT. 1999. Ochrobactrum anthropi bacteremia associated with a catheter in an immunocompromised child and review of the pediatric literature. Pediatr Infect Dis J 18:658660.
137. Naik C,, Kulkarni H,, Darabi A,, Bhanot N. 2013. Ochrobactrum anthropi: a rare cause of pneumonia. J Infect Chemother 19:162165.
138. Ezzedine H,, Mourad M,, Van Ossel C,, Logghe C,, Squifflet JP,, Renault F,, Wauters G,, Gigi J,, Wilmotte L,, Haxha JJ. 1994. An outbreak of Ochrobactrum anthropi bacteraemia in five organ transplant patients. J Hosp Infect 27:3542.
139. Apisarnthanarak A,, Kiratisin P,, Mundy LM. 2005. Evaluation of Ochrobactrum intermedium bacteremia in a patient with bladder cancer. Diagn Microbiol Infect Dis 53:153155.
140. Holmes B,, Segers P,, Coenye T,, Vancanneyt M,, Vandamme P. 2006. Pannonibacter phragmitetus, described from a Hungarian soda lake in 2003, had been recognized several decades earlier from human blood cultures as Achromobacter groups B and E. Int J Syst Evol Microbiol 56:29452948.
141. Jenks PJ,, Shaw EJ. 1997. Recurrent septicaemia due to “Achromobacter group B.” J Infect 34:143145.
142. Kämpfer P,, Rosselló-Mora R,, Scholz HC,, Wellinder-Olsson C,, Falsen E,, Busse HJ. 2006. Description of Pseudochrobactrum gen. nov., with the two species Pseudochrobactrum asaccharolyticum sp. nov. and Pseudochrobactrum saccharolyticum sp. nov. Int J Syst Evol Microbiol 56:18231829.
143. Young JM,, Kuykendall LD,, Martínez-Romero E,, Kerr A,, Sawada H. 2001. A revision of Rhizobium Frank 1889, with an emended description of the genus, and the inclusion of all species of Agrobacterium Conn 1942 and Allorhizobium undicola de Lajundie et al. 1998 as new combinations: Rhizobium radiobacter, R. rhizogenes, R. rubi, R. undicola and R. vitis. Int J Syst Evol Microbiol 51:89103.
144. Dunne WMJr, Tillman J,, Murray JC. 1993. Recovery of a strain of Agrobacterium radiobacter with a mucoid phenotype from an immunocompromised child with bacteremia. J Clin Microbiol 31:25412543.
145. von Graevenitz A,. 1985. Ecology, clinical significance, and antimicrobial susceptibility of infrequently encountered glucose-nonfermenting gram-negative rods, p 181–232. In Gilardi GL (ed), Nonfermentative Gram-Negative Rods: Laboratory Identification and Clinical Aspects. Marcel Dekker, Inc, New York, NY.
146. Nozue H,, Hayashi T,, Hashimoto Y,, Ezaki T,, Hamasaki K,, Ohwada K,, Terawaki Y. 1992. Isolation and characterization of Shewanella alga from human clinical specimens and emendation of the description of S. alga Simidu et al., 1990, 335. Int J Syst Bacteriol 42:628634.
147. Khashe S,, Janda JM. 1998. Biochemical and pathogenic properties of Shewanella alga and Shewanella putrefaciens. J Clin Microbiol 36:783787.
148. Vignier N,, Barreau M,, Olive C,, Baubion E,, Théodose R,, Hochedez P,, Cabié A. 2013. Human infection with Shewanella putrefaciens and S. algae: report of 16 cases in Martinique and review of the literature. Am J Trop Med Hyg 89:151156.
149. Wauters G,, Janssens M,, De Baere T,, Vaneechoutte M,, Deschaght P. 2012. Isolates belonging to CDC group II-i belong predominantly to Sphingobacterium mizutaii Yabuuchi 1983: emended descriptions of S. mizutaii and of the genus Sphingobacterium. Int J Syst Evol Microbiol 62:25982601.
150. Takeuchi M,, Yokota A. 1992. Proposals of Sphingobacterium faecium sp. nov., Sphingobacterium piscium sp. nov., Sphingobacterium heparinum comb. nov., Sphingobacterium thalpophilum comb. nov. and two genospecies of the genus Sphingobacterium, and synonymy of Flavobacterium yabuuchiae and Sphingobacterium spiritivorum. J Gen Appl Microbiol 38:465482.
151. Yabuuchi E,, Kaneko T,, Yano I,, Moss CW,, Miyoshi N. 1983. Sphingobacterium gen. nov., Sphingobacterium spiritivorum comb. nov., Sphingobacterium multivorum com. nov., Sphingobacterium mizutae sp. nov., and Flavobacterium indologenes sp. nov.: glucose-nonfermenting gram-negative rods in CDC groups IIk-2 and IIb. Int J Syst Evol Microbiol 33:580598.
152. Grimaldi D,, Doloy A,, Fichet J,, Bourgeois E,, Zuber B,, Wajsfisz A,, Mira JP,, Poyart C,, Pène F. 2012. Necrotizing fasciitis and septic shock related to the uncommon gram-negative pathogen Sphingobacterium multivorum. J Clin Microbiol 50:202203.
153. Holmes B,, Owen RJ,, Weaver RE. 1981. Flavobacterium multivorum, a new species isolated from human clinical specimens and previously known as group IIK, biotype 2. Int J Syst Evol Microbiol 31:2134.
154. Holmes B,, Owen RJ,, Hollis DG. 1982. Flavobacterium spiritivorum, a new species isolated from human clinical specimens. Int J Syst Bacteriol 32:157165.
155. Holmes B,, Owen RJ,, Evans A,, Malnick H,, Willcox WR. 1977. Pseudomonas paucimobilis, a new species isolated from human clinical specimens, the hospital environment, and other sources. Int J Syst Evol Microbiol 27:133146.
156. Yabuuchi E,, Yano I,, Oyaizu H,, Hashimoto Y,, Ezaki T,, Yamamoto H. 1990. Proposals of Sphingomonas paucimobilis gen. nov. and comb. nov., Sphingomonas parapaucimobilis sp. nov., Sphingomonas yanoikuyae sp. nov., Sphingomonas adhaesiva sp. nov., Sphingomonas capsulata comb. nov., and two genospecies of the genus Sphingomonas. Microbiol Immunol 34:99119.
157. Takeuchi M,, Hamana K,, Hiraishi A. 2001. Proposal of the genus Sphingomonas sensu stricto and three new genera, Sphingobium, Novosphingobium and Sphingopyxis, on the basis of phylogenetic and chemotaxonomic analyses. Int J Syst Evol Microbiol 51:14051417.
158. Hsueh PR,, Teng LJ,, Yang PC,, Chen YC,, Pan HJ,, Ho SW,, Luh KT. 1998. Nosocomial infections caused by Sphingomonas paucimobilis: clinical features and microbiological characteristics. Clin Infect Dis 26:676681.
159. Lin JN,, Lai CH,, Chen YH,, Lin HL,, Huang CK,, Chen WF,, Wang JL,, Chung HC,, Liang SH,, Lin HH. 2010. Sphingomonas paucimobilis bacteremia in humans: 16 case reports and a literature review. J Microbiol Immunol Infect 43:3542.
160. Dauga C,, Gillis M,, Vandamme P,, Ageron E,, Grimont F,, Kersters K,, de Mahenge C,, Peloux Y,, Grimont PA. 1993. Balneatrix alpica gen. nov., sp. nov., a bacterium associated with pneumonia and meningitis in a spa therapy centre. Res Microbiol 144:3546.
161. Holmes B,, Steigerwalt AG,, Weaver RE,, Brenner DJ. 1986. Weeksella zoohelcum sp. nov. (formerly group IIj), from human clinical specimens. Syst Appl Microbiol 8:191196.
162. Montejo M,, Aguirrebengoa K,, Ugalde J,, Lopez L,, Saez Nieto JA,, Hernández JL. 2001. Bergeyella zoohelcum bacteremia after a dog bite. Clin Infect Dis 33:16081609.
163. Hsueh PR,, Teng LJ,, Ho SW,, Hsieh WC,, Luh KT. 1996. Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices. J Clin Microbiol 34:19081913.
164. Eshwara VK,, Sasi A,, Munim F,, Purkayastha J,, Lewis LE,, Mukhopadhyay C. 2013. Neonatal meningitis and sepsis by Chryseobacterium indologenes: a rare and resistant bacterium. Indian J Pediatr 81:611613.
165. Hendaus MA,, Zahraldin K. 2013. Chryseobacterium indologenes meningitis in a healthy newborn: a case report. Oman Med J 28:133134.
166. Perilli M,, Caporale B,, Celenza G,, Pellegrini C,, Docquier JD,, Mezzatesta M,, Rossolini GM,, Stefani S,, Amicosante G. 2007. Identification and characterization of a new metallo-β-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes. Antimicrob Agents Chemother 51:29882990.
167. Kämpfer P,, Vaneechoutte M,, Lodders N,, De Baere T,, Avesani V,, Janssens M,, Busse HJ,, Wauters G. 2009. Description of Chryseobacterium anthropi sp. nov. to accommodate clinical isolates biochemically similar to Kaistella koreensis and Chryseobacterium haifense, proposal to reclassify Kaistella koreensis as Chryseobacterium koreense comb. nov. and emended description of the genus Chryseobacterium. Int J Syst Evol Microbiol 59:24212428.
168. Vaneechoutte M,, Kämpfer P,, De Baere T,, Avesani V,, Janssens M,, Wauters G. 2007. Chryseobacterium hominis sp. nov., to accommodate clinical isolates biochemically similar to CDC groups II-h and II-c. Int J Syst Evol Microbiol 57:26232628.
169. Yassin AF,, Hupfer H,, Siering C,, Busse HJ. 2010. Chryseobacterium treverense sp. nov., isolated from a human clinical source. Int J Syst Evol Microbiol 60:19931998.
170. Kim KK,, Kim MK,, Lim JH,, Park HY,, Lee ST. 2005. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov. Int J Syst Evol Microbiol 55:12871293.
171. Ceyhan M,, Celik M. 2011. Elizabethkingia meningosepticum (Chryseobacterium meningosepticum) infections in children. Int J Pediatr 2011:215237. 10.1155/2011/215237.
172. Bloch KC,, Nadarajah R,, Jacobs R. 1997. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine (Baltimore) 76:3041.
173. Hung PP,, Lin YH,, Lin CF,, Liu MF,, Shi ZY. 2008. Chryseobacterium meningosepticum infection: antibiotic susceptibility and risk factors for mortality. J Microbiol Immunol Infect 41:137144.
174. Lin PY,, Chu C,, Su LH,, Huang CT,, Chang WY,, Chiu CH. 2004. Clinical and microbiological analysis of bloodstream infections caused by Chryseobacterium meningosepticum in nonneonatal patients. J Clin Microbiol 42:33533355.
175. Vandamme P,, Bernardet JF,, Segers P,, Kersters K,, Holmes B. 1994. New perspectives in the classification of the flavobacteria: description of Chryseobacterium gen. nov., Bergeyella gen. nov., and Empedobacter nom. rev. Int J Syst Evol Microbiol 44:827831.
176. Holmes B,, Weaver RE,, Steigerwalt AG,, Brenner DJ. 1988. A taxonomic study of Flavobacterium spiritivorum and Sphingobacterium mizutae: proposal of Flavobacterium yabuuchiae sp. nov. and Flavobacterium mizutaii comb. nov. Int J Syst Evol Microbiol 38:348353.
177. Kämpfer P,, Avesani V,, Janssens M,, Charlier J,, De Baere T,, Vaneechoutte M. 2006. Description of Wautersiella falsenii gen. nov., sp. nov., to accommodate clinical isolates phenotypically resembling members of the genera Chryseobacterium and Empedobacter. Int J Syst Evol Microbiol 56:23232329.
178. van der Velden LB,, de Jong AS,, de Jong H,, de Gier RP,, Rentenaar RJ. 2012. First report of a Wautersiella falsenii isolated from the urine of an infant with pyelonephritis. Diagn Microbiol Infect Dis 74:404405.
179. Holmes B,, Steigerwalt AG,, Weaver RE,, Brenner DJ. 1986. Weeksella virosa gen. nov., sp. nov. (formerly group IIf), found in human clinical specimens. Syst Appl Microbiol 8:185190.
180. Chang JC,, Hsueh PR,, Wu JJ,, Ho SW,, Hsieh WC,, Luh KT. 1997. Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods. Antimicrob Agents Chemother 41:13011306.
181. Hsueh PR,, Chang JC,, Teng LJ,, Yang PC,, Ho SW,, Hsieh WC,, Luh KT. 1997. Comparison of Etest and agar dilution method for antimicrobial susceptibility testing of Flavobacterium isolates. J Clin Microbiol 35:10211023.
182. Yamada Y,, Katsura K,, Kawasaki H,, Widyastuti Y,, Saono S,, Seki T,, Uchimura T,, Komagata K. 2000. Asaia bogorensis gen. nov., sp. nov., an unusual acetic acid bacterium in the α-Proteobacteria. Int J Syst Evol Microbiol 50:823829.
183. Juretschko S,, Beavers-May TK,, Stovall SH. 2010. Nosocomial infection with Asaia lannensis in two paediatric patients with idiopathic dilated cardiomyopathy. J Med Microbiol 59:848852.
184. Katsura K,, Kawasaki H,, Potacharoen W,, Saono S,, Seki T,, Yamada Y,, Uchimura T,, Komagata K. 2001. Asaia siamensis sp. nov., an acetic acid bacterium in the α-Proteobacteria. Int J Syst Evol Microbiol 51:559563.
185. Snyder RW,, Ruhe J,, Kobrin S,, Wasserstein A,, Doline C,, Nachamkin I,, Lipschutz JH. 2004. Asaia bogorensis peritonitis identified by 16S ribosomal RNA sequence analysis in a patient receiving peritoneal dialysis. Am J Kidney Dis 44:E15E17.
186. Tuuminen T,, Heinäsmäki T,, Kerttula T. 2006. First report of bacteremia by Asaia bogorensis, in a patient with a history of intravenous-drug abuse. J Clin Microbiol 44:30483050.
187. Moore JE,, McCalmont M,, Xu J,, Millar BC,, Heaney N. 2002. Asaia sp., an unusual spoilage organism of fruit-flavored bottled water. Appl Environ Microbiol 68:41304131.
188. Han XY,, Pham AS,, Tarrand JJ,, Rolston KV,, Helsel LO,, Levett PN. 2003. Bacteriologic characterization of 36 strains of Roseomonas species and proposal of Roseomonas mucosa sp. nov. and Roseomonas gilardii subsp. rosea subsp. nov. Am J Clin Pathol 120:256264.
189. Rihs JD,, Brenner DJ,, Weaver RE,, Steigerwalt AG,, Hollis DG,, Yu VL. 1993. Roseomonas, a new genus associated with bacteremia and other human infections. J Clin Microbiol 31:32753283.
190. Urakami T,, Araki H,, Suzuki KI,, Komagata K. 1993. Further studies of the genus Methylobacterium and description of Methylobacterium aminovorans sp. nov. Int J Syst Evol Microbiol 43:504513.
191. Patt TE,, Cole GC,, Hanson RS. 1976. Methylobacterium, a new genus of facultatively methylotrophic bacteria. Int J Syst Evol Microbiol 26:226229.
192. Engler C,, Norton R. 2001. Recurrent Methylobacterium mesophilicum sepsis associated with haemodialysis. Pathology 33:536537.
193. Hornei B,, Luneberg E,, Schmidt-Rotte H,, Maab M,, Weber K,, Heits F,, Frosch M,, Solbach W. 1999. Systemic infection of an immunocompromised patient with Methylobacterium zatmanii. J Clin Microbiol 37:248250.
194. Kaye KM,, Macone A,, Kazanjian PH. 1992. Catheter infection caused by Methylobacterium in immunocompromised hosts: report of three cases and review of the literature. Clin Infect Dis 14:10101014.
195. Simon A,, Völz S,, Reiffert SM,, Bölefahr H,, Marklein G,, Büttner R,, Hepping N,, Bode U,, Fleischhack G. 2007. Protracted cervical lymphadenitis with Mycobacterium avium and Methylobacterium mesophilicum. Pediatr Infect Dis J 26:971.
196. Brown WJ,, Sautter RL,, Crist AEJr. 1992. Susceptibility testing of clinical isolates of Methylobacterium species. Antimicrob Agents Chemother 36:16351638.
197. I,, Rolston KV,, Han XY. 2004. Clinical significance of Roseomonas species isolated from catheter and blood samples: analysis of 36 cases in patients with cancer. Clin Infect Dis 38:15791584.
198. Shokar NK,, Shokar GS,, Islam J,, Cass AR. 2002. Roseomonas gilardii infection: case report and review. J Clin Microbiol 40:47894791.
199. Struthers M,, Wong J,, Janda JM. 1996. An initial appraisal of the clinical significance of Roseomonas species associated with human infections. Clin Infect Dis 23:729733.
200. Wang CM,, Lai CC,, Tan CK,, Huang YC,, Chung KP,, Lee MR,, Hwang KP,, Hsueh PR. 2012. Clinical characteristics of infections caused by Roseomonas species and antimicrobial susceptibilities of the isolates. Diagn Microbiol Infect Dis 72:199203.
201. Alvarez-Buylla A,, Culebras E,, Picazo JJ. 2012. Identification of Acinetobacter species: is Bruker biotyper MALDI-TOF mass spectrometry a good alternative to molecular techniques? Infect Genet Evol 12:345349.
202. Eigner U,, Holfelder M,, Oberdorfer K,, Betz-Wild U,, Bertsch D,, Fahr AM. 2009. Performance of a matrix-assisted laser desorption ionization–time-of-flight mass spectrometry system for the identification of bacterial isolates in the clinical routine laboratory. Clin Lab 55:289296.
203. Fernández-Olmos A,, García-Castillo M,, Morosini MI,, Lamas A,, Máiz L,, Cantón R. 2012. MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients. J Cyst Fibros 11:5962.


Generic image for table

Oxidase-negative, indole-negative, nonfermentative, Gram-negative rods: the genus

Generic image for table

Accuracy of MALDI-TOF MS compared to other identification methods

Generic image for table

Oxidase-positive, indole-negative, trypsin-negative, coccoid GNF

Generic image for table

Oxidase-positive, indole-negative, trypsin-positive GNF

Generic image for table

Oxidase-positive, indole-positive GNF

Generic image for table

Pink-pigmented GNF


This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error